AIMEDBIO is a spin-off company from Samsung Medical Center with the sole purpose of pursuing after attainable treatment solutions to patients with refractory brain disease, including cancer, in hopes of providing better quality of life. Our primary objective is based on data-driven personalized treatment to address current medical unmet needs in the field of brain disease through international collaborations that we have solidified through years of close partnership.
We have an excellent research team with profound achievements, own R&D pipelines with outstanding drug development platform and are building strong global networks with key opinion leaders in the field.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 67 Jeongui-Ro, Songpa-Gu, 11f,mk Tower,korea, Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.aimedbio.com
- HQ
- Seoul
Aimed Bio Inc. Questions
Aimed Bio Inc.'s website is http://www.aimedbio.com
Aimed Bio Inc.'s LinkedIn profile is https://kr.linkedin.com/company/aimed-bio-inc
Aimed Bio Inc. has
13 employees.
View email and phone details for 13
employees at Aimed Bio Inc..
Aimed Bio Inc.'s industry is
Pharmaceutical Manufacturing
Aimed Bio Inc.'s top competitors are
Genequantum Healthcare (Suzhou) Co., Ltd,
Baxter International Inc.,
Novelty Nobility Inc.,
Genotwin Inc.,
Samsung Medical Center,
Geninus Inc.,
Avelos Therapeutics,
Avatamed,
Sk Bioscience,
Samsung Biologics.
Aimed Bio Inc.'s categories are Pharmaceutical Manufacturing
Aimed Bio Inc.'s founding year is 2018
